TickerFactsScreenerDevelopers

Adaptimmune Therapeutics PLC (ADAPY) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $14.20M2017: $37.83M2018: $59.51M2019: $1.12M2020: $3.96M2021: $6.15M2022: $27.15M2023: $60.28M2024: $178.03M$178.03M
2016Revenue (USD)2024
Fiscal YearRevenueChange YoY
2024$178.03M+195.3%
2023$60.28M+122.0%
2022$27.15M+341.5%
2021$6.15M+55.4%
2020$3.96M+252.8%
2019$1.12M-98.1%
2018$59.51M+57.3%
2017$37.83M+166.5%
2016$14.20M—